Antoine Papiernik - Sep 8, 2023 Form 4 Insider Report for Shockwave Medical, Inc. (SWAV)

Role
Director
Signature
/s/ Wade Estey, as attorney-in-fact for Antoine Papiernik
Stock symbol
SWAV
Transactions as of
Sep 8, 2023
Transactions value $
$0
Form type
4
Date filed
9/12/2023, 08:20 PM
Previous filing
Jul 6, 2023
Next filing
May 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Other $0 -21.9K -96.75% $0.00 736 Sep 8, 2023 Direct F1
holding SWAV Common Stock 34.2K Sep 8, 2023 By Sofinnova Capital VII FCPR F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a distribution of Common Stock of the Issuer by the reporting person without consideration to Sofinnova Capital VII FCPR ("Sofinnova VII") in accordance with the employment agreement between the reporting person and Sofinnova Partners SAS.
F2 Represents shares directly held by Sofinnova VII and includes 21,926 shares received pursuant to the distribution reported hereinabove. The reporting person is one of the managing partners of Sofinnova Partners SAS, a French corporation and the management company of Sofinnova VII. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest.